Sternum

Cloud and Medical Device Cybersecurity: The FDA's 2023 Guidelines, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, January 15, 2024

TORONTO, Jan. 15, 2024 /PRNewswire-PRWeb/ -- Discover an informative webinar decoding The Food and Drug Administration's (FDA) 2023 guidelines about the cloud and medical device cybersecurity landscape. Medical device cybersecurity has undergone a game-changing transformation with The FDA's updated 2023 guidelines, seamlessly integrating both medical device and cloud computing aspects.

Key Points: 
  • Attendees will learn how to continuously monitor devices and cloud systems, and their software code, to meet the FDA guidelines.
  • TORONTO, Jan. 15, 2024 /PRNewswire-PRWeb/ -- Discover an informative webinar decoding The Food and Drug Administration's (FDA) 2023 guidelines about the cloud and medical device cybersecurity landscape.
  • Medical device cybersecurity has undergone a game-changing transformation with The FDA's updated 2023 guidelines, seamlessly integrating both medical device and cloud computing aspects.
  • Join this insightful webinar to be part of a forward-thinking community eager to master the future of medical device cybersecurity in the cloud era.

BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic Tumor

Retrieved on: 
Thursday, November 30, 2023

After only 3 cycles, patient experienced a remarkable improvement of eye-bulging “proptosis” caused by orbital metastatic breast cancer tumor behind the eye.

Key Points: 
  • After only 3 cycles, patient experienced a remarkable improvement of eye-bulging “proptosis” caused by orbital metastatic breast cancer tumor behind the eye.
  • BriaCell’s clinical team reported a patient with extensive metastatic breast cancer who had failed all available therapies.
  • “We were excited to offer her the latest treatments and thrilled to share in her success and joy.”
    The noted responder, a post-menopausal metastatic breast cancer patient (the “Remarkable Responder”), experienced a remarkable improvement of proptosis caused by breast cancer tumors behind the eye, resulting in significant pain reduction in the ocular region.
  • BriaCell had previously reported a similar case of a remarkable response with 100% resolution of an eye-bulging orbital tumor ( release here ).

Closure Devices Lead Sternal Closure Systems Market: Innovations in Surgical Techniques Boost Adoption - ResearchAndMarkets.com

Retrieved on: 
Friday, November 10, 2023

These systems play a vital role in the closure and stabilization of the sternum following open-heart surgery or sternotomy.

Key Points: 
  • These systems play a vital role in the closure and stabilization of the sternum following open-heart surgery or sternotomy.
  • As these diseases become more common, there is a rising demand for sternal closure systems.
  • Advancements in Surgical Techniques: Innovations in surgical techniques, including minimally invasive cardiac surgeries, have led to a growing need for specialized sternal closure systems that offer stability, reduced trauma, and enhanced patient outcomes.
  • Closure Devices Dominate the Market: Closure devices, including rigid plate systems, wire cerclage systems, and interlocking systems, generated the highest revenue in the sternal closure systems market in 2022.

Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest

Retrieved on: 
Monday, October 23, 2023

DUBLIN, Oct. 23, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, has received U.S. Food and Drug Administration (FDA) approval for the Aurora EV-ICD™ MRI SureScan™ (Extravascular Implantable Cardioverter-Defibrillator) and Epsila EV™ MRI SureScan™ defibrillation lead to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest (SCA). The Aurora EV-ICD system is the first-of-its-kind to provide the life-saving benefits of traditional, transvenous ICDs with a lead (thin wire) placed under the breastbone, outside of the heart and veins. The Aurora EV-ICD delivers lifesaving defibrillation, anti-tachycardia pacing (ATP), and back-up (pause-prevention) pacing therapies via a device similar in size, shape, and longevity to traditional, transvenous ICDs.

Key Points: 
  • In the coming weeks, the Aurora EV-ICD system will be commercially available on a limited basis in the United States.
  • [1] Additionally, 33 defibrillation shocks were avoided1 by having ATP – which paces the heart to interrupt and terminate a dangerous rhythm – programmed "on."
  • Traditional ICDs typically are implanted below the collarbone, with the lead(s) threaded through the veins and into the heart.
  • Boersma, M.D., Ph.D., cardiologist at St. Antonius Hospital, Nieuwegein, The Netherlands, and a limited launch is underway in select European countries.

Update: SS Innovations Launches Innovative Robotic Cardiac Surgery Program in India

Retrieved on: 
Tuesday, October 3, 2023

FORT LAUDERDALE, FL, Oct. 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announces the launch of an innovative robotic cardiac surgery program in India utilizing its flagship SSi Mantra surgical robotic system.

Key Points: 
  • FORT LAUDERDALE, FL, Oct. 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announces the launch of an innovative robotic cardiac surgery program in India utilizing its flagship SSi Mantra surgical robotic system.
  • More than 20 robotic cardiac surgeries have been successfully performed using SS Innovations’ surgical robotic system in India, to date.
  • It was always my goal to revive robotic cardiac surgery and while developing the Mantra Surgical Robotic System; I was acutely aware of how our platform would always include cardiac surgery as a viable treatment option for many patients globally.
  • “SS Innovations plans to launch multiple robotic cardiac surgical programs throughout India, followed by programs internationally.

SS Innovations Launches Innovative Robotic Cardiac Surgery Program in India

Retrieved on: 
Tuesday, October 3, 2023

FORT LAUDERDALE, FL, Oct. 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announces the launch of an innovative robotic cardiac surgery program in India utilizing its flagship SSi Mantra surgical robotic system.

Key Points: 
  • FORT LAUDERDALE, FL, Oct. 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announces the launch of an innovative robotic cardiac surgery program in India utilizing its flagship SSi Mantra surgical robotic system.
  • More than 20 robotic cardiac surgeries have been successfully performed using SS Innovations’ surgical robotic system in India, to date.
  • It was always my goal to revive robotic cardiac surgery and while developing the Mantra Surgical Robotic System, I was acutely aware of how our platform would always include cardiac surgery as a viable treatment option for many patients globally.
  • “SS Innovations plans to launch multiple robotic cardiac surgical programs throughout India, followed by programs internationally.

Abyrx Receives FDA Clearance for MONTAGE® Settable Bone Putty for Use in Cardiothoracic Surgery

Retrieved on: 
Tuesday, September 26, 2023

STAMFORD, Conn., Sept. 26, 2023 /PRNewswire/ -- Abyrx, Inc. (http://abyrx.com), a leading biomaterial sciences company with a focus on therapeutic technologies for use during surgical procedures, today announced that the United States Food and Drug Administration (FDA) has provided regulatory clearance for the company's MONTAGE® Settable Bone Putty for use in cardiothoracic surgery following sternotomy. This represents the first time that the FDA has granted clearance for the use of a settable bone putty on the sternum, and it follows previous FDA clearances for MONTAGE as a bone void filler, cranial cement, and hemostatic bone putty.

Key Points: 
  • This represents the first time that the FDA has granted clearance for the use of a settable bone putty on the sternum, and it follows previous FDA clearances for MONTAGE as a bone void filler, cranial cement, and hemostatic bone putty.
  • MONTAGE is unique as a moldable putty that adheres to bleeding bone and rapidly hardens to achieve bone-like properties after application.
  • Upon application, MONTAGE controls bleeding and eliminates the need for topical agents known to prevent bone healing, such as bone wax.
  • For over a decade, Dr. Fedak has championed enhanced sternal closure using settable biomaterials to accelerate patient recovery after open heart surgery.

Wearing a well-fitting sports bra can improve your performance – an expert advises how to find one

Retrieved on: 
Thursday, August 24, 2023

In a survey of UK female athletes, 51% experienced breast pain and 29% said that poorly fitting bras affected their performance.

Key Points: 
  • In a survey of UK female athletes, 51% experienced breast pain and 29% said that poorly fitting bras affected their performance.
  • Before the Tokyo Olympics and Paralympics, Team GB athletes and para-athletes were offered a bra prescription service in which they were fitted with a sports bra based on an individual assessment.
  • Around 97% of those prescribed a bra reported benefits in comfort, fit and support, while 17% said it had significantly improved their performance.
  • This article is part of Women’s Health Matters, a series about the health and wellbeing of women and girls around the world.
  • When comparing physical activity between low and high breast support conditions, there is evidence that performance is reduced in low support.

What makes a good sports bra?

    • A compression bra is usually made from one piece of strong elastic, and it works to compress breast tissue to the chest to limit breast movement.
    • Encapsulation bras are designed to support and limit the movement of each breast individually, while combination bras have characteristics of both compression and encapsulation bras.
    • For a high-support sports bra, there are five characteristics to look for that have been linked to reduced breast movement.
    • High-support sports bras also tend to have a higher neckline – for every 1cm higher the neckline, breast bounce is reduced by 1%.

New pulmonary valve benefits quality, length of life

Retrieved on: 
Tuesday, August 8, 2023

The FDA-approved valve consists of a catheter-based stent (called Alterra), an artificial heart valve (SAPIEN 3) and the opportunity to implant the stent and valve without the need for open-heart surgery.

Key Points: 
  • The FDA-approved valve consists of a catheter-based stent (called Alterra), an artificial heart valve (SAPIEN 3) and the opportunity to implant the stent and valve without the need for open-heart surgery.
  • She says this new technology will expand peoples' lives and enhance their quality of life.
  • This current pulmonary valve that is in place allows you to be ready for another less-invasive procedure when the time comes.
  • Dr. Patel and her team administered four pulmonary valves in patients this spring, with two more procedures planned in August.

Zephyr Project Welcomes Analog Devices, Arduino and Technology Innovation Institute as New Members as it Launches the 3.4 Release

Retrieved on: 
Tuesday, June 20, 2023

SAN FRANCISCO , June 20, 2023 /PRNewswire/ -- Today, the Zephyr® Project announced that Analog Devices (ADI) has joined as a Platinum member as well as Arudino and Technology Innovation Institute (TII) as Silver members. Zephyr, an open source project at the Linux Foundation that builds a secure, connected and flexible RTOS for future-proof and resource-constrained devices, is easy to deploy and manage. It is a proven RTOS ecosystem created by developers for developers.

Key Points: 
  • SAN FRANCISCO , June 20, 2023 /PRNewswire/ -- Today, the Zephyr® Project announced that Analog Devices (ADI) has joined as a Platinum member as well as Arudino and Technology Innovation Institute (TII) as Silver members.
  • The project recently achieved several milestones including surpassing 80,000 commits since it was released in open source in 2015.
  • Zephyr RTOS supports over 450 boards running embedded microcontrollers from Arm and RISC-V to Tensilica, NIOS, ARC and x86 as single and multicore systems.
  • "Arduino is proud to support the Zephyr Project and join the remarkable community," said Fabio Violante, CEO of Arduino.